Loading…
Dexamethasone for preventing postoperative nausea and vomiting after mastectomy
Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns...
Saved in:
Published in: | Medicine (Baltimore) 2020-07, Vol.99 (30), p.e21417-e21417 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53 |
---|---|
cites | cdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53 |
container_end_page | e21417 |
container_issue | 30 |
container_start_page | e21417 |
container_title | Medicine (Baltimore) |
container_volume | 99 |
creator | Xu, LeiLai Xie, XiaoHong Gu, XiDong |
description | Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy.
Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3.
Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P |
doi_str_mv | 10.1097/MD.0000000000021417 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2434485557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</originalsourceid><addsrcrecordid>eNpdkctO3UAMhkeoCA6XJ0BCWXYTmGsms0GqOIVWArGB9cjJOJy0SSadmRzK2xM4XFq8sWR__m35J-SI0RNGjT69Xp7Qj-BMMr1FFkyJIlemkF_IYq6qXBstd8lejL8oZUJzuUN2BdeGaWUW5GaJf6HHtILoB8waH7Ix4BqH1A732ehj8iMGSO0aswGmiJDB4LK179sXApqEIeshJqyT7x8PyHYDXcTD17xP7i6-357_yK9uLn-ef7vKa6moyo0GUzNXUnSF002DApkpgSEXNbrKlUaquuJFUXKHFQXFndANFEaWpZCVEvvkbKM7TlWPrp4PDtDZMbQ9hEfrobX_d4Z2Ze_92mpRaiqfBb6-CgT_Z8KYbN_GGrsOBvRTtFwKKUullJ5RsUHr4GMM2LyvYdQ-W2Gvl_azFfPU8b8Xvs-8_X4G5AZ48N38xPi7mx4w2BVCl1YvekobnnPKKZ1to_nsH1XiCc2Zlpg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2434485557</pqid></control><display><type>article</type><title>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</title><source>Open Access: PubMed Central</source><source>HEAL-Link subscriptions: Lippincott Williams & Wilkins</source><source>IngentaConnect Journals</source><creator>Xu, LeiLai ; Xie, XiaoHong ; Gu, XiDong</creator><creatorcontrib>Xu, LeiLai ; Xie, XiaoHong ; Gu, XiDong</creatorcontrib><description>Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy.
Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3.
Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P < .00001) in the dexamethasone group, while, no statistically significant difference was observed between the two groups in terms of visual analog scale at 24 hours (weighted mean difference = -0.56, 95% CI: -1.24 to 0.13, P = 0.11).
Not only does Dexamethasone reduce the incidence of PONV but also decreases postoperative pain. However, we still need larger samples and higher quality studies to determine the relationship between symptoms and administration time to reach the conclusion.
PROSPERO CRD 42018118575.</description><identifier>ISSN: 0025-7974</identifier><identifier>ISSN: 1536-5964</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000021417</identifier><identifier>PMID: 32791759</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Antiemetics - therapeutic use ; Dexamethasone - therapeutic use ; Humans ; Mastectomy - adverse effects ; Pain, Postoperative - etiology ; Pain, Postoperative - prevention & control ; Postoperative Nausea and Vomiting - etiology ; Postoperative Nausea and Vomiting - prevention & control ; Systematic Review and Meta-Analysis</subject><ispartof>Medicine (Baltimore), 2020-07, Vol.99 (30), p.e21417-e21417</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</citedby><cites>FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</cites><orcidid>0000-0003-3458-1862</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387045/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387045/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32791759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, LeiLai</creatorcontrib><creatorcontrib>Xie, XiaoHong</creatorcontrib><creatorcontrib>Gu, XiDong</creatorcontrib><title>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy.
Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3.
Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P < .00001) in the dexamethasone group, while, no statistically significant difference was observed between the two groups in terms of visual analog scale at 24 hours (weighted mean difference = -0.56, 95% CI: -1.24 to 0.13, P = 0.11).
Not only does Dexamethasone reduce the incidence of PONV but also decreases postoperative pain. However, we still need larger samples and higher quality studies to determine the relationship between symptoms and administration time to reach the conclusion.
PROSPERO CRD 42018118575.</description><subject>Antiemetics - therapeutic use</subject><subject>Dexamethasone - therapeutic use</subject><subject>Humans</subject><subject>Mastectomy - adverse effects</subject><subject>Pain, Postoperative - etiology</subject><subject>Pain, Postoperative - prevention & control</subject><subject>Postoperative Nausea and Vomiting - etiology</subject><subject>Postoperative Nausea and Vomiting - prevention & control</subject><subject>Systematic Review and Meta-Analysis</subject><issn>0025-7974</issn><issn>1536-5964</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkctO3UAMhkeoCA6XJ0BCWXYTmGsms0GqOIVWArGB9cjJOJy0SSadmRzK2xM4XFq8sWR__m35J-SI0RNGjT69Xp7Qj-BMMr1FFkyJIlemkF_IYq6qXBstd8lejL8oZUJzuUN2BdeGaWUW5GaJf6HHtILoB8waH7Ix4BqH1A732ehj8iMGSO0aswGmiJDB4LK179sXApqEIeshJqyT7x8PyHYDXcTD17xP7i6-357_yK9uLn-ef7vKa6moyo0GUzNXUnSF002DApkpgSEXNbrKlUaquuJFUXKHFQXFndANFEaWpZCVEvvkbKM7TlWPrp4PDtDZMbQ9hEfrobX_d4Z2Ze_92mpRaiqfBb6-CgT_Z8KYbN_GGrsOBvRTtFwKKUullJ5RsUHr4GMM2LyvYdQ-W2Gvl_azFfPU8b8Xvs-8_X4G5AZ48N38xPi7mx4w2BVCl1YvekobnnPKKZ1to_nsH1XiCc2Zlpg</recordid><startdate>20200724</startdate><enddate>20200724</enddate><creator>Xu, LeiLai</creator><creator>Xie, XiaoHong</creator><creator>Gu, XiDong</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3458-1862</orcidid></search><sort><creationdate>20200724</creationdate><title>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</title><author>Xu, LeiLai ; Xie, XiaoHong ; Gu, XiDong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antiemetics - therapeutic use</topic><topic>Dexamethasone - therapeutic use</topic><topic>Humans</topic><topic>Mastectomy - adverse effects</topic><topic>Pain, Postoperative - etiology</topic><topic>Pain, Postoperative - prevention & control</topic><topic>Postoperative Nausea and Vomiting - etiology</topic><topic>Postoperative Nausea and Vomiting - prevention & control</topic><topic>Systematic Review and Meta-Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, LeiLai</creatorcontrib><creatorcontrib>Xie, XiaoHong</creatorcontrib><creatorcontrib>Gu, XiDong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, LeiLai</au><au>Xie, XiaoHong</au><au>Gu, XiDong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2020-07-24</date><risdate>2020</risdate><volume>99</volume><issue>30</issue><spage>e21417</spage><epage>e21417</epage><pages>e21417-e21417</pages><issn>0025-7974</issn><issn>1536-5964</issn><eissn>1536-5964</eissn><abstract>Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy.
Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3.
Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P < .00001) in the dexamethasone group, while, no statistically significant difference was observed between the two groups in terms of visual analog scale at 24 hours (weighted mean difference = -0.56, 95% CI: -1.24 to 0.13, P = 0.11).
Not only does Dexamethasone reduce the incidence of PONV but also decreases postoperative pain. However, we still need larger samples and higher quality studies to determine the relationship between symptoms and administration time to reach the conclusion.
PROSPERO CRD 42018118575.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>32791759</pmid><doi>10.1097/MD.0000000000021417</doi><orcidid>https://orcid.org/0000-0003-3458-1862</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2020-07, Vol.99 (30), p.e21417-e21417 |
issn | 0025-7974 1536-5964 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387045 |
source | Open Access: PubMed Central; HEAL-Link subscriptions: Lippincott Williams & Wilkins; IngentaConnect Journals |
subjects | Antiemetics - therapeutic use Dexamethasone - therapeutic use Humans Mastectomy - adverse effects Pain, Postoperative - etiology Pain, Postoperative - prevention & control Postoperative Nausea and Vomiting - etiology Postoperative Nausea and Vomiting - prevention & control Systematic Review and Meta-Analysis |
title | Dexamethasone for preventing postoperative nausea and vomiting after mastectomy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A29%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dexamethasone%20for%20preventing%20postoperative%20nausea%20and%20vomiting%20after%20mastectomy&rft.jtitle=Medicine%20(Baltimore)&rft.au=Xu,%20LeiLai&rft.date=2020-07-24&rft.volume=99&rft.issue=30&rft.spage=e21417&rft.epage=e21417&rft.pages=e21417-e21417&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000021417&rft_dat=%3Cproquest_pubme%3E2434485557%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2434485557&rft_id=info:pmid/32791759&rfr_iscdi=true |